Reuters Archives - World Asthma Foundation

May 17, 2016

AstraZeneca asthma drug hits goal, to enter competitive market – Reuters

AstraZeneca asthma drug hits goal, to enter competitive market
Reuters
L) drive to rebuild its portfolio of new medicines received a boost with positive results for an experimental biotech drug for severe asthma that the company previously flagged as a potential $2 billion-a-year seller. Benralizumab, which is likely to …
AstraZeneca: Asthma drug trial results positiveMarketWatch
Astrazeneca Reports Results On Benralizumab Phase III Programme In Severe AsthmaNasdaq
TOP NEWS: AstraZeneca Gets Positive Benralizumab Phase III Trial ResultsLondon South East (registration) (blog)

all 6 news articles »

View full post on asthma – Google News

May 17, 2016

AstraZeneca boosted by good results for biotech asthma drug – Reuters

Reuters

AstraZeneca boosted by good results for biotech asthma drug
Reuters
LONDON AstraZeneca's (AZN.L) drive to rebuild its portfolio of new medicines received a boost on Tuesday with positive results for a biotech drug for severe asthma that the company has previously flagged as a potential $2 billion-a-year product.
AstraZeneca: Asthma drug trial results positiveMarketWatch
Astrazeneca Reports Results On Benralizumab Phase III Programme In Severe AsthmaNasdaq
TOP NEWS: AstraZeneca Gets Positive Benralizumab Phase III Trial ResultsLondon South East (registration) (blog)

all 4 news articles »

View full post on asthma – Google News

May 11, 2016

The asthma talk teens need before they leave for college – Reuters

The asthma talk teens need before they leave for college
Reuters
(Reuters Health) – When teens have asthma, the “sex talk” isn't the only tough discussion parents should make sure kids get before heading off to college. The teen years are a good time for parents to start encouraging children to talk with doctors …

and more »

View full post on asthma – Google News

May 2, 2016

Yoga may help relieve asthma symptoms – Reuters UK

Yoga may help relieve asthma symptoms
Reuters UK
“Breathing techniques are an essential part of yoga when targeting asthma,” Cramer said. “While posture-based yoga interventions and mere meditation might not be this effective; complex yoga forms (incorporating yoga postures, breathing, and meditation …

and more »

View full post on asthma – Google News

May 2, 2016

Yoga may help relieve asthma symptoms – Reuters

Yoga may help relieve asthma symptoms
Reuters
“Breathing techniques are an essential part of yoga when targeting asthma,” Cramer said. “While posture-based yoga interventions and mere meditation might not be this effective; complex yoga forms (incorporating yoga postures, breathing, and meditation …

and more »

View full post on asthma – Google News

April 29, 2016

Yates fails drugs test using asthma inhaler: team – Reuters

BBC News

Yates fails drugs test using asthma inhaler: team
Reuters
LONDON British rider Simon Yates, a strong contender to make Team GB's Olympic cycling squad, has failed a drugs test due to an "administrative error" over the use of an asthma inhaler, his team Orica-GreenEDGE said on Friday. The Bury-born 23-year-old …
Simon Yates: British cyclist fails drug test 'after asthma inhaler error'BBC News
British cyclist Simon Yates fails drug test 'after asthma inhaler error'ITV News
Cycling-Yates fails drugs test using asthma inhaler – teamDaily Mail

all 33 news articles »

View full post on asthma – Google News

March 29, 2016

BRIEF-Japan approves GlaxoSmithkline’s asthma drug Nucala – Reuters

BRIEF-Japan approves GlaxoSmithkline's asthma drug Nucala
Reuters
March 29 Glaxosmithkline Plc. * Receives marketing authorisation for nucala (mepolizumab) in Japan. * Nucala is licensed in japan for adults and adolescents aged 12 years or older Source text for Eikon: Further company coverage: (Reporting By London …

View full post on asthma – Google News

March 24, 2016

Better inhaler lessons can prevent asthma emergencies – Reuters

Reuters

Better inhaler lessons can prevent asthma emergencies
Reuters
Reuters Health – A major weakness of asthma care is that many patients don't know how to use inhalers to deliver life-saving medicine when they're gasping for air. The fix may be as simple as taking more time to teach patients how the devices work, a U …
Inhaler Misuse is Rampant in COPDMD Magazine

all 8 news articles »

View full post on asthma – Google News

January 8, 2016

BUZZ-Vectura: all-time high on completing asthma therapy trial – Reuters

Proactive Investors USA & Canada

BUZZ-Vectura: all-time high on completing asthma therapy trial
Reuters
… ** Vectura up over 5 pct to all-time high & top FTSE 250 mid-cap gainer after it completes a clinical trial for generic asthma therapy VR315 in the U.S., bringing it closer to a commercial launch. ** Drug developer also reveals that its partner for …
Drug developer Vectura on a high as asthma treatment completes US clinical trialSwindon Business News
Vectura Group Completes Clinical Trial For VR315 Asthma TreatmentLondon South East (registration) (blog)
Vectura Completes Clinical Trial For VR315 In US; Stock UpNasdaq
Proactive Investors USA & Canada –Yahoo Finance UK –Stock Market Wire
all 7 news articles »

View full post on asthma – Google News

December 21, 2015

Independent group says new Glaxo asthma drug far too expensive – Reuters

Independent group says new Glaxo asthma drug far too expensive
Reuters
Dec 21 An independent nonprofit organization that evaluates clinical and cost effectiveness of new medicines found the price of GlaxoSmithKline's new drug for severe asthma should be as much as 76 percent lower to justify its value, according to the …

and more »

View full post on asthma – Google News